Earnings Feed
Start Free
Home/Filings/4/0001235802-11-000124
4//SEC Filing

Nealon John F 4

Accession 0001235802-11-000124

CIK 0001114200other
View on SEC.govCompany Profile

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 2:51 PM ET

Size

37.6 KB

Accession

0001235802-11-000124

Insider Transaction Report

Form 4
Period: 2011-06-17
AMERICAN MEDICAL SYSTEMS HOLDINGS INCAMMD
Nealon John F
Sr. VP, Business Development
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−12,500→ 0 total
    Exercise: $21.38Exp: 2013-02-08→ Common Stock (12,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−25,000→ 0 total
    Exercise: $14.36Exp: 2015-03-05→ Common Stock (25,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−8,304→ 0 total
    Exercise: $14.94Exp: 2014-02-18→ Common Stock (8,304 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−19,999→ 0 total
    Exercise: $19.69Exp: 2012-05-05→ Common Stock (19,999 underlying)
  • Disposition to Issuer

    Common Stock

    2011-06-17−5,888→ 0 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−6,696→ 0 total
    Exercise: $14.94Exp: 2014-02-18→ Common Stock (6,696 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−1→ 0 total
    Exercise: $19.69Exp: 2012-05-05→ Common Stock (1 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−31,373→ 0 total
    Exercise: $18.46Exp: 2017-02-11→ Common Stock (31,373 underlying)
  • Disposition to Issuer

    Common Stock

    2011-06-17−3,275→ 5,888 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−5,070→ 0 total
    Exercise: $19.72Exp: 2015-01-23→ Common Stock (5,070 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−19,930→ 0 total
    Exercise: $19.72Exp: 2015-01-23→ Common Stock (19,930 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−25,000→ 0 total
    Exercise: $20.39Exp: 2014-02-08→ Common Stock (25,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−50,000→ 0 total
    Exercise: $10.82Exp: 2016-02-09→ Common Stock (50,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−35,210→ 0 total
    Exercise: $20.05Exp: 2018-02-10→ Common Stock (35,210 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-06-17−10,457→ 31,373 total
    Exercise: $18.46Exp: 2017-02-11→ Common Stock (10,457 underlying)
Footnotes (15)
  • [F1]Pursuant to the merger of a wholly-owned subsidiary of Endo Pharmaceutials Holdings Inc. ("Endo") with and into American Medical Systems Holdings, Inc. (the "Merger"), such shares were disposed of in exchange for $98,250 in cash.
  • [F10]This option, which has vested, was canceled in the Merger in exchange for a cash payment of $240,250 representing the difference between the exercise price of the option and the $30.00 per share price.
  • [F11]This option, which has vested, was canceled in the Merger in exchange for a cash payment of $391,125 representing the difference between the exercise price of the option and the $30.00 per share price.
  • [F12]This option, which has vested, was canceled in the Merger in exchange for a cash payment of $958,750 representing the difference between the exercise price of the option and the $30.00 per share price.
  • [F13]This option, which vested with respect to 25% of the shares on March 31, 2011 and with respect to the remaining shares, quarterly over the next three years, was canceled with respect to 10,457 shares in the Merger in exchange for a cash payment of $120,673.78 representing the difference between the exercise price of the option and the $30.00 per share price.
  • [F14]This option, which vested with respect to 25% of the shares on March 31, 2011 and with respect to the remaining shares, quarterly over the next three years, was assumed by Endo in the Merger and replaced with an option to purchase 23,702 shares of Endo common stock with an exercise price of $24.44 per share.
  • [F15]This option, which vested with respect to 25% of the shares on March 31, 2012 and with respect to the remaining shares, quarterly over the next three years, was assumed by Endo in the Merger and replaced with an option to purchase 26,601 shares of Endo common stock with an exercise price of $26.54 per share.
  • [F2]These restricted shares were assumed by Endo in the Merger in exchange for 4,448 restricted shares of Endo common stock, having a market value of $38.32 per share on the effective date of the Merger. The vesting terms of the new Endo restricted stock grants will remain the same as the vesting terms of the old grants.
  • [F3]This option, which has vested, was canceled in the Merger in exchange for a cash payment of $100,841.76 representing the difference between the exercise price of the option and the $30.00 per share price.
  • [F4]This option, which has vested, was canceled in the Merger in exchange for a cash payment of $125,058.24 representing the difference between the exercise price of the option and the $30.00 per share price.
  • [F5]This option, which has vested, was canceled in the Merger in exchange for a cash payment of $52,106.93 representing the difference between the exercise price of the option and the $30.00 per share price.
  • [F6]This option, which has vested, was canceled in the Merger in exchange for a cash payment of $204,830.58 representing the difference between the exercise price of the option and the $30.00 per share price.
  • [F7]This option, which has vested, was canceled in the Merger in exchange for a cash payment of $10.31 representing the difference between the exercise price of the option and the $30.00 per share price.
  • [F8]This option, which has vested, was canceled in the Merger in exchange for a cash payment of $206,189.69 representing the difference between the exercise price of the option and the $30.00 per share price.
  • [F9]This option, which has vested, was canceled in the Merger in exchange for a cash payment of $107,750 representing the difference between the exercise price of the option and the $30.00 per share price.

Documents

1 file

Issuer

AMERICAN MEDICAL SYSTEMS HOLDINGS INC

CIK 0001114200

→
Entity typeother

Related Parties

1
  • filerCIK 0001325381

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 2:51 PM ET
Size
37.6 KB
View on SEC.gov